Imatinib in pulmonary arterial hypertension: c-Kit inhibition
about
Myeloid Targets for Pulmonary Arterial Hypertension: Time for Another Look.Novel Therapeutic Strategies for Reducing Right Heart Failure Associated Mortality in Fibrotic Lung Diseases.KIT Inhibition by Imatinib in Patients with Severe Refractory Asthma.Immune cells and autoantibodies in pulmonary arterial hypertension.2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
P2860
Imatinib in pulmonary arterial hypertension: c-Kit inhibition
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Imatinib in pulmonary arterial hypertension: c-Kit inhibition
@ast
Imatinib in pulmonary arterial hypertension: c-Kit inhibition
@en
Imatinib in pulmonary arterial hypertension: c-Kit inhibition
@nl
type
label
Imatinib in pulmonary arterial hypertension: c-Kit inhibition
@ast
Imatinib in pulmonary arterial hypertension: c-Kit inhibition
@en
Imatinib in pulmonary arterial hypertension: c-Kit inhibition
@nl
prefLabel
Imatinib in pulmonary arterial hypertension: c-Kit inhibition
@ast
Imatinib in pulmonary arterial hypertension: c-Kit inhibition
@en
Imatinib in pulmonary arterial hypertension: c-Kit inhibition
@nl
P2093
P2860
P356
P1476
Imatinib in pulmonary arterial hypertension: c-Kit inhibition
@en
P2093
Deborah A Quinn
Fernando Torres
Franck Rahaghi
Kewal Asosingh
Paul Hassoun
Raed Dweik
Raymond Benza
Robert Frantz
Samar Farha
Serpil Erzurum
P2860
P304
P356
10.1086/677359
P577
2014-09-01T00:00:00Z